Your browser doesn't support javascript.
loading
Person-centred deprescribing for patients living with frailty: a qualitative interview study and proposal of a collaborative model.
Peat, George; Fylan, Beth; Breen, Liz; Raynor, David K; Olaniyan, Janice; Alldred, David P.
Afiliación
  • Peat G; School of Health Sciences, University of York, York, UK.
  • Fylan B; School of Pharmacy and Medical Sciences University of Bradford, Bradford, UK.
  • Breen L; NIHR Yorkshire and Humber Patient Safety Translational Research Centre (YH PSTRC), Bradford, UK.
  • Raynor DK; School of Pharmacy and Medical Sciences University of Bradford, Bradford, UK.
  • Olaniyan J; NIHR Yorkshire and Humber Patient Safety Translational Research Centre (YH PSTRC), Bradford, UK.
  • Alldred DP; School of Pharmacy and Medical Sciences University of Bradford, Bradford, UK.
Int J Pharm Pract ; 31(3): 282-289, 2023 May 07.
Article en En | MEDLINE | ID: mdl-37068006
ABSTRACT

OBJECTIVES:

(1) Present deprescribing experiences of patients living with frailty, their informal carers and healthcare professionals; (2) interpret whether their experiences are reflective of person-centred/collaborative care; (3) complement our findings with existing evidence to present a model for person-centred deprescribing for patients living with frailty, based on a previous collaborative care model.

METHODS:

Qualitative design in English primary care (general practice). Semi-structured interviews were undertaken immediately post-deprescribing and 5/6 weeks later with nine patients aged 65+ living with frailty and three informal carers of patients living with frailty. Fourteen primary care professionals with experience in deprescribing were also interviewed. In total, 38 interviews were conducted. A two-staged approach to data analysis was undertaken. KEY

FINDINGS:

Three themes were developed attitudes, beliefs and understanding of medicines management and responsibility; attributes of a collaborative, person-centred deprescribing consultation; organisational factors to support person-centred deprescribing. Based on these findings and complementary to existing evidence, we offer a model for person-centred deprescribing for patients living with frailty.

CONCLUSIONS:

Previous models of deprescribing for patients living with frailty while, of value, do not consider the contextual factors that govern the implementation and success of models in practice. In this paper, we propose a novel person-centred model for deprescribing for people living with frailty, based on our own empirical findings, and the wider evidence base.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Deprescripciones / Fragilidad Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Int J Pharm Pract Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Deprescripciones / Fragilidad Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Int J Pharm Pract Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido